- Active Internal Calls for Limited Submission Nominations
- Active Calls for NON-Limited External Opportunities
- Email LSO@vanderbilt.edu if you are interested in an opportunity not listed below or have questions regarding the LSO submission process.
Active Internal Calls for Limited Submission Nominations
Internal review process required to choose institutional nominees
Limited Submission Eligibility Guidelines
The following tags serve as a guide for submission instructions.
Vanderbilt (VU + VUMC)
- VU and VUMC submit collaboratively to this LSO. ALL investigators should follow the guidelines posted on this site.
- VU and VUMC submit separately to this LSO. VUMC investigators should follow the guidelines posted on this site. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.
- High-profile or prestigious awards of particular interest to Vanderbilt investigators
Internal Applications due December 21st
The purpose of the Health Resources & Services Administration Rural Health Innovation and Transformation Technical Assistance program is to provide technical assistance (TA) to rural stakeholders and the public to help them understand and engage in the value-based care landscape in the context of rural health care. HRSA expects approximately to fund one project at $500,000 per year for three years.
In an effort to control health care costs and improve the quality of care, public and private payers have increasingly implemented initiatives to encourage value-based care. Value-based care programs reward health care providers for the quality of care through the realignment of financial incentives towards value over volume. Because of the unique economic factors affecting rural providers, the implementation and effects of value-based care initiatives may look different in rural, low-volume settings. A major goal of this funding opportunity is to support the ability of rural providers to participate and succeed in current and emerging payment and delivery system models designed to provide value-based care.
Internal Application Process:
Anyone interested in being considered as one of VUMC’s nominees must submit the following (in PDF format) to LSO@vanderbilt.edu by 5:00 p.m. on December 21, 2018:
- Brief (2 page maximum) research proposal including summary budget;
- Statement of support from department chair/ center director;
- NIH Biosketch
Submissions should reference the program name in the subject line of the email.
Internal Applications due January 3rd
VUMC may submit up to two proposals, one in Medical Research and one in Science and Engineering, for the W.M. Keck Foundation Research Program. We are currently soliciting concept papers to be presented to the Keck Foundation for feedback in a consultation phone call. The goal of the program is to benefit humanity by supporting work that has a distinctive and novel approach, questions a prevailing paradigm, or has the potential to break open new territory in a field. Grants are typically awarded for roughly $1,000,000 and abstracts from previously funded proposals can be found here.
Program Priorities for Funding:
- Focus on important and emerging areas of research
- Have the potential to develop breakthrough technologies, instrumentation or methodologies
- Are innovative, distinctive and interdisciplinary
- Demonstrate a high level of risk due to unconventional approaches, or by challenging the prevailing paradigm
- Have the potential for transformative impact, such as the founding of a new field of research, the enabling of observations not previously possible, or the altered perception of a previously intractable problem
- Does not focus on clinical or translational research, treatment trials or research for the sole purpose of drug development
- Fall outside the mission of public funding agencies
- Demonstrate that private philanthropy generally, and the W. M. Keck Foundation in particular, is essential to the project’s success
Internal Application Process:
Anyone interested in being considered as VUMC's nominee must submit the following (in PDF format) to LSO@vanderbilt.edu by 5 p.m. on January 3, 2019.
- 1-page Concept Paper (See guidelines below)
- Statement of support from department chair/center director;
- NIH Biosketch
Concept Paper Requirements:
- Must be single page with 12 point font and 1 inch margins
- Please indicate the area of emphasis for the project – “medical research” or “science and engineering research”
- Include an overview of the proposed project emphasizing any unique aspects and pilot studies.
- Include a description of the methodologies and key personnel
- Include a brief justification of the need for Keck support (evidence that proposed research is a poor fit for federal funding opportunities, i.e. reviewer comments or program officer discussion)
- Include an estimated budget broken down, if possible, by major areas, e.g., personnel, equipment, consumable supplies, etc. (budgets can be rough approximations at this stage)
Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.
Vanderbilt (VU + VUMC)
Internal Applications due January 8th
Vanderbilt may submit Research Grant, Supportive Care Research Grant, and (NEW!) Consortium Research Grant proposals for the St. Baldrick’s Foundation spring grant cycle. The St. Baldrick’s Foundation is a nonprofit organization raising funds for childhood cancer research. All projects must have direct applicability and relevance to pediatric cancer.
Topics of interest include, but are not limited to:
- Adolescents & young adults
- Survivorship, outcomes, and quality of life
- Supportive care
- Epidemiology and pediatric cancer predispositions
- Precision medicine
- Alternative & complementary therapies
There is particularly high interest in the following:
- Brain tumors – all types, including rare forms
- Burkitt lymphoma
- Complementary and alternative therapies
- Langerhans Cell Histiocytosis
- Rhabdoid tumors
Research Grants: These grants may be either laboratory, clinical, or epidemiological in nature. The average grant will be 1 year and $100,000 for a specific hypothesis-driven research project.
Supportive Care Research Grants: These grants focus on areas related to the supportive care of children and adolescents with cancer. Examples include but are not limited to: studies related to symptom clusters, patient-reported outcomes or quality of life, health communication, health promotion, and psychosocial support across the trajectory from diagnosis to survivorship or end-of-life care. The average grant will be 1 year and $50,000 for a specific hypothesis-driven research project.
Consortium Grants: These grants are for team science to support program projects, for a group of 3-5 or more institutions solving key questions in childhood cancer. Existing consortia or new/not-yet-formed consortia are all eligible. The average grant will be 1-5 years, $100,000 - $500,000 annually. Grants are made with the intent to support the full term, with funds committed one year at a time, based on acceptable progress.
- Applicants should review full eligibility and budget requirements in the grant guidelines document.
- Research Grant applicants should hold at least an M.D./D.O. or Ph.D. degree by the date the award becomes effective.
- Supportive Care Research Grant applicants should hold at least a Ph.D., D.N.P., M.D./D.O. degree, and Ph.D. nurses are encouraged to apply, by the date the award becomes effective.
- During each grant cycle, a researcher can only apply once as the lead Principal Investigator.
- St. Baldrick’s funds may not be used for human embryonic stem cell research.
- No institutional overhead or indirect funding is allowed.
Internal Selection Process:
- Anyone interested in being considered as one of Vanderbilt’s nominees must submit the following (in a single PDF) to LSO@vanderbilt.edu by January 8, 2019 at 5:00 p.m.
- Lay abstract (200 words)
- Scientific abstract (200 words)
- 1 page Letter of Intent
- Name of the institution(s) involved in the proposal
- Title of the proposed research project
- Area of focus of the research project (childhood cancer type or other research focus)
- Relevance of the proposed research project to the mission of St. Baldrick’s, to cure childhood cancers
- Brief rationale for the proposed research project
- Brief timeline of the progression of research
- Consortia applicants only must clearly note in the LOI if they are a new or an existing consortium
- Project budget (Realistic for the project; Max $100,000 for Research Grant; $50,000 for Supportive Care Grant; $500,000 annually for Consortium)
- Brief statement of support from department chair/center director
- NIH Biosketch
*Please reference the Grant Type in the subject line of the email.* You may apply to internal competitions for one or more grant types- please submit a separate application for each grant type. Following internal selection, Vanderbilt’s nominee(s) will submit a Letter of Intent to St. Baldrick’s by January 31, 2019.
Active Calls for NON-Limited External Opportunities
Internal review process NOT required- Submit directly to Sponsor
LOIs due December 17th
This program focuses on projects that have the potential to advance the care of individuals living with BRCA1 and BRCA2 mutations. Research grant applications in basic science, prevention, early detection, or targeted therapeutics and relevant to the study of BRCA1/2 will be considered. Submission by early stage investigators is encouraged. Full proposals are due January 28, 2019.
Epidemiology Grants: Applications due December 17th
- Young Investigator Grants: Applications due December 17th
Interested VUMC applicants are strongly encouraged to contact Adele White, Director- VUMC Corporate and Foundation Relations (email@example.com) for feedback on proposal development.
Applications due January 11th
These $1.3M grants are intended to provide support for the investigation of key unresolved research questions in autism, particularly those that connect etiologies to brain function and behavior. Risk and novelty are welcome but are not required criteria for the proposal to be considered meritorious. Competitive applications will have preliminary data or other relevant groundwork that justifies substantial investment on the proposed topic.
Applications due January 17th
- PFI contains two separate tracks for submission: PFI-Technology Translation (PFI-TT) and PFI-Research Partnerships (PFI-RP).
- There is no limit on the number of Tech Transfer (PFI-TT) applications.
- Note that the Research Partnerships (PFI-RP) track is limited to 1/institution. Contact firstname.lastname@example.org by Dec. 1 if you are interested in the PFI-RP track.
Applications due February 1st
The L’Oréal USA For Women in Science fellowship program awards five women postdoctoral scientists annually with grants of $60,000 each for their contributions in Science, Technology, Engineering and Math (STEM) fields and commitment to serving as role models for younger generations. The program is the U.S. component of the L'Oréal-UNESCO For Women in Science International Fellowships program. Celebrating its fifteenth year in the U.S., the For Women in Science program has awarded 75 postdoctoral women scientists nearly $4 million grants.
L’Oréal USA partners with the American Association for the Advancement of Science (AAAS) to manage the program’s application and peer-review process. Each year, the program attracts talented applicants from diverse STEM fields, representing some of the nation’s leading academic institutions and laboratories.
Applications due March 12
The Cystic Fibrosis Foundation announces a Request for Applications (RFA) to identify and support highly meritorious proposals in gene editing that offer potential to repair or circumvent CFTR mutations in individuals with CF. The idea for this RFA developed after the Foundation's "CF Gene Editing Workshop: Advancing Gene Editing Technologies and Tools for Cystic Fibrosis" in August 2018. A key concept that emerged from this workshop was that investigators without experience in CF research would be more inclined to become involved in this work if access to CF tools and reagents, as well as CF knowledge, were available.
To bring new technologies to the CF field, investigators without experience in CF research are encouraged to apply.
There are four award types:
- Collaborative Award: Up to $75,000 per year (max $250,000) per project per year within the collaborative project plus 8% indirect costs for up to 3 years
- Pilot and Feasibility Award: Up to $75,000 per year plus 8% indirect costs for up to 2 years
- Postdoctoral Fellowship Award: First-year fellowship up to $63,100; Second-year fellowship up to $65,450
- Research Award: Up to $200,000 per year plus 8% indirect costs for up to 3 years
Applications due March 15th
The Science & PINS Prize is awarded for innovative research that modulates neural activity through physical (electrical, magnetic, optical) stimulation of targeted sites in the nervous system with implications for translational medicine. Established in 2016, the prize is administered by Science and Science Translational Medicine and awarded annually for outstanding research as described in a 1,500 word essay based on research performed in the past three years. The winner of the Science & PINS Prize for Neuromodulation is awarded US$25,000 and publication of his or her essay in Science.
The Prize is awarded annually to one young researcher for the most outstanding neuromodulation research conducted by him/her during the past three years. (Entrants must be a Junior Investigator with an advanced degree received in the last 10 years and must be 45 years or younger as of January 1, 2018.)